Literature DB >> 8804949

Gas exchange, expiratory flow obstruction and the clinical spectrum of asthma.

P D Wagner1, G Hedenstierna, R Rodriguez-Roisin.   

Abstract

More than any other chronic respiratory disease, asthma is characterized by functional and clinical variability: expiratory flow obstruction, dyspnoea and wheezing may be absent, mild, or severe. Moreover, pulmonary gas exchange often does not closely relate to measured airway obstruction. Accordingly, the correlation between arterial oxygen tension and airflow (Pa,O2) rate indices of obstruction is poor, both in a single patient over time, and within groups of clinically similar patients. Here, these concepts are extended by examining relationships between airflow obstruction and gas exchange across the clinical spectrum of asthma (from asymptomatic to acute severe). Six individual studies encompassing 86 patients are analysed together, focusing on: 1) airways obstruction; 2) arterial blood gas data; and 3) the distribution of alveolar ventilation/perfusion (V'A/Q') ratios, measured by the multiple inert gas elimination technique. V'A/Q' mismatching was greater than normal even when forced expiratory volume in one second (FEV1) was normal, but with increasing severity of airways obstruction there was essentially no further deterioration in gas exchange until FEV1 reached about 40% of predicted normal values. Then, with little further airways obstruction, gas exchange rapidly worsened, Pa,O2 falling to about 50 torr. This study emphasizes that what has been observed in individual patients and within clinically similar patient groups can be extended across the spectrum of asthma severity: airways obstruction and gas exchange are poorly correlated. Furthermore, these results suggest that spirometric data alone may not adequately define remission, nor clearly identify those patients liable to serious gas exchange deterioration.

Entities:  

Mesh:

Year:  1996        PMID: 8804949     DOI: 10.1183/09031936.96.09061278

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Ventilation and perfusion lung scintigraphy of allergen-induced airway responses in atopic asthmatic subjects.

Authors:  Krishnan Parameswaran; Andrew C Knight; Niall P Keaney; E David Williams; Ian K Taylor
Journal:  Can Respir J       Date:  2007 Jul-Aug       Impact factor: 2.409

2.  Hypoxic Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in Asthma.

Authors:  Vanessa J Kelly; Kathryn A Hibbert; Puja Kohli; Mamary Kone; Elliot E Greenblatt; Jose G Venegas; Tilo Winkler; R Scott Harris
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

3.  Quantifying the shape of maximal expiratory flow-volume curves in healthy humans and asthmatic patients.

Authors:  Paolo B Dominelli; Yannick Molgat-Seon; Glen E Foster; Giulio S Dominelli; Hans C Haverkamp; William R Henderson; A William Sheel
Journal:  Respir Physiol Neurobiol       Date:  2015-09-18       Impact factor: 1.931

Review 4.  Mechanisms of hypoxemia.

Authors:  Malay Sarkar; N Niranjan; P K Banyal
Journal:  Lung India       Date:  2017 Jan-Feb

Review 5.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

6.  Wheeze is an unreliable endpoint for bronchial methacholine challenges in preschool children.

Authors:  Lora Stewart; Naomi Miyazawa; Ronina Covar; Christopher Mjaanes; Reed Shimamoto; Melanie Gleason; Diego Peroni; Joseph D Spahn; Pasquale Comberiati
Journal:  Pediatr Allergy Immunol       Date:  2022-04       Impact factor: 5.464

7.  Estimated Prevalence of Asthma in US Children With Developmental Disabilities.

Authors:  Luyu Xie; Andrew Gelfand; George L Delclos; Folefac D Atem; Harold W Kohl; Sarah E Messiah
Journal:  JAMA Netw Open       Date:  2020-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.